Total Payments
$10,810
2024 Payments
$127.14
Companies
10
Transactions
49
Medicare Patients
1,940
Medicare Billing
$105,200
Payment Breakdown by Category
Other$6,500 (60.1%)
Consulting$2,120 (19.6%)
Food & Beverage$1,533 (14.2%)
Travel$656.77 (6.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,500 | 3 | 60.1% |
| Consulting Fee | $2,120 | 1 | 19.6% |
| Food and Beverage | $1,533 | 42 | 14.2% |
| Travel and Lodging | $656.77 | 3 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | $7,408 | 8 | $0 (2018) |
| Ferring Pharmaceuticals Private Limited | $2,120 | 1 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $521.43 | 21 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $171.92 | 4 | $0 (2019) |
| Edwards Lifesciences Corporation | $157.96 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $155.75 | 6 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $127.14 | 1 | $0 (2024) |
| PFIZER INC. | $97.18 | 5 | $0 (2021) |
| Sensible Medical Innovations Inc | $25.60 | 1 | $0 (2019) |
| BOSTON SCIENTIFIC CORPORATION | $24.13 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $127.14 | 1 | E.R. Squibb & Sons, L.L.C. ($127.14) |
| 2021 | $2,249 | 7 | Ferring Pharmaceuticals Private Limited ($2,120) |
| 2020 | $136.84 | 6 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($106.11) |
| 2019 | $503.65 | 11 | Edwards Lifesciences Corporation ($157.96) |
| 2018 | $7,779 | 23 | PORTOLA PHARMACEUTICALS, INC. ($7,408) |
| 2017 | $14.10 | 1 | AstraZeneca Pharmaceuticals LP ($14.10) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/13/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $127.14 | General |
| Category: Hematology | ||||||
| 12/21/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $31.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/06/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2021 | Ferring Pharmaceuticals Private Limited | — | Consulting Fee | Cash or cash equivalent | $2,120.44 | General |
| 07/20/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/18/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/18/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/11/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/28/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $35.90 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/30/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $27.94 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/17/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/25/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/28/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.48 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/20/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.77 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $27.77 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/15/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $124.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/10/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/21/2019 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $157.96 | General |
| Category: Transcatheter Heart Valves | ||||||
| 06/12/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $48.17 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/11/2019 | Sensible Medical Innovations Inc | ReDS system (Device) | Food and Beverage | Cash or cash equivalent | $25.60 | General |
| Category: Heart failure | ||||||
| 03/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/20/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 438 | 502 | $100,377 | $20,053 |
| 2022 | 9 | 411 | 469 | $96,126 | $21,782 |
| 2021 | 12 | 532 | 638 | $129,001 | $31,248 |
| 2020 | 11 | 559 | 623 | $138,405 | $32,117 |
Total Patients
1,940
Total Services
2,232
Medicare Billing
$105,200
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 175 | 181 | $51,585 | $10,103 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 55 | $21,010 | $6,262 | 29.8% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 20 | 21 | $5,964 | $1,240 | 20.8% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 115 | 118 | $15,951 | $1,239 | 7.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 41 | 70 | $2,310 | $475.15 | 20.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 22 | 23 | $2,024 | $422.97 | 20.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 22 | 23 | $1,357 | $281.75 | 20.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 11 | 11 | $176.00 | $28.71 | 16.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 219 | 236 | $67,260 | $14,333 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 41 | $15,662 | $4,587 | 29.3% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2022 | 17 | 17 | $4,828 | $1,088 | 22.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 23 | 24 | $2,112 | $481.76 | 22.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 45 | 66 | $2,178 | $466.00 | 21.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 16 | 16 | $1,680 | $322.48 | 19.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 23 | 24 | $1,416 | $318.12 | 22.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2022 | 18 | 18 | $558.00 | $115.72 | 20.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2022 | 25 | 27 | $432.00 | $70.54 | 16.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 217 | 229 | $65,265 | $14,218 | 21.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 92 | $35,144 | $10,620 | 30.2% |
| 93350 | Ultrasound examination of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Facility | 2021 | 22 | 22 | $6,248 | $1,371 | 21.9% |
| 93312 | Insertion of probe in esophagus for heart ultrasound examination including interpretation and report | Facility | 2021 | 13 | 13 | $5,538 | $1,313 | 23.7% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Facility | 2021 | 11 | 11 | $3,410 | $785.95 | 23.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 58 | 102 | $3,366 | $751.45 | 22.3% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 37 | 37 | $3,256 | $736.92 | 22.6% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2021 | 23 | 23 | $2,415 | $517.88 | 21.4% |
About Dr. Jason Lazar, M.D
Dr. Jason Lazar, M.D is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295729721.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Lazar, M.D has received a total of $10,810 in payments from pharmaceutical and medical device companies, with $127.14 received in 2024. These payments were reported across 49 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,500).
As a Medicare-enrolled provider, Lazar has provided services to 1,940 Medicare beneficiaries, totaling 2,232 services with total Medicare billing of $105,200. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 09/12/2005
- Last Updated 01/05/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1295729721
Products in Payments
- BEVYXXA (Drug) $7,408
- LifeVest (Device) $521.43
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $157.96
- XARELTO (Drug) $155.75
- LOKELMA (Drug) $144.94
- REBLOZYL (Biological) $127.14
- ELIQUIS (Drug) $97.18
- BRILINTA (Drug) $26.98
- ReDS system (Device) $25.60
- RHYTHMIA (Device) $24.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799